during the quickly evolving area of oncology exploration, exact and efficient mutation screening is very important for acquiring qualified therapies. The KRAS Services Platform performs a pivotal function in this landscape by featuring comprehensive solutions for KRAS mutation profiling and Examination. KRAS mutations, found in around ninety five%